Authors
Loading...
This review examines β-hydroxybutyrate’s impact on metabolic disorders and neurodegenerative diseases, suggesting new therapeutic avenues.
Pali et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: